Racial patterns of peripheral T-Cell lymphoma incidence and survival in the United States

Journal of Clinical Oncology

Volumn 34, Issue 9, 2016, Pages 963-971

  Adams, Scott V ^a   Newcomb, Polly A ^a   Shustov, Andrei R ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALASKA NATIVE; AMERICAN INDIAN; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; ASIAN; BLACK PERSON; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISPANIC; HUMAN; LARGE CELL LYMPHOMA; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATURAL KILLER CELL LEUKEMIA; NK T CELL LYMPHOMA; PACIFIC ISLANDER; PERIPHERAL T CELL LYMPHOMA; PERIPHERAL T CELL LYMPHOMA NOT OTHERWISE SPECIFIED; PRIORITY JOURNAL; SURVIVAL TIME; T CELL LEUKEMIA; UNITED STATES; ALASKA; ETHNOLOGY; INCIDENCE; INUIT; LYMPHOMA, T-CELL, PERIPHERAL; MORTALITY; OCEANIC ANCESTRY GROUP; STATISTICS AND NUMERICAL DATA;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALASKA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; INUITS; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; OCEANIC ANCESTRY GROUP; SEER PROGRAM; UNITED STATES;

EID: 84962129173     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.63.5540     Document Type: Article

References (30)

1. Vose J, Armitage J, Weisenburger D: International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes. J Clin Oncol 26: 4124-4130, 2008
2. Anderson JR, Armitage JO, Weisenburger DD: Epidemiology of the non-Hodgkin's lymphomas: Distributions of the major subtypes differ by geographic locations - Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 9: 717-720, 1998
3. ∗0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology. Int J Cancer 87: 195-199, 2000
4. Tajima K, Hinuma Y: Epidemiology of HTLV-I/II in Japan and the world. Gann Monogr Canc Res 39: 129-149, 1992
5. Morton LM, Wang SS, Devesa SS, et al: Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107: 265-276, 2006
6. Swerdlow SH, Campo E, Harris NL, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. (ed 4). Lyon, France, International Agency for Research on Cancer, 2008
7. Abouyabis AN, Shenoy PJ, Lechowicz MJ, et al: Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma 49: 2099-2107, 2008
8. Shiels MS, Engels EA, Linet MS, et al: The epidemic of non-Hodgkin lymphoma in the United States: Disentangling the effect of HIV, 1992-2009. Cancer Epidemiol Biomarkers Prev 22: 1069-1078, 2013
9. Ai WZ, Chang ET, Fish K, et al: Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: A population-based study. Br J Haematol 156: 626-632, 2012
10. Petrich AM, Helenowski IB, Bryan LJ, et al: Factors predicting survival in peripheral T-cell lymphoma in the USA: A population-based analysis of 8802 patients in the modern era. Br J Haematol 168: 708-718, 2015
11. Iqbal J, Wright G, Wang C, et al: Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-Cell Lymphoma Project: Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 123: 2915-2923, 2014
12. ∗Stat Database: Incidence - SEER 18 Regs Research Data 1 Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub (2000-2012) Katrina/Rita Population Adjustment. - Linked to County Attributes - Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission. http://seer.cancer.gov/
13. Howlader N, Noone AM, Krapcho M, et al: SEER Cancer Statistics Review 1975-2012. Bethesda, MD, National Cancer Institute, 2015
14. Zippin C, Lum D, Hankey BF: Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 76: 2343-2350, 1995
15. Clegg LX, Feuer EJ, Midthune DN, et al: Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 94: 1537-1545, 2002
16. National Cancer Institute, Surveillance, Epidemiology, and End Results Program: Months survived based on complete dates. Updated 2013. http://seer.cancer.gov/survivaltime/
17. Adamo MB, Johnson CH, Ruhl JL, et al: 2011 SEER Program Coding and Staging Manual. Bethesda, MD, National Cancer Institute, NIH Publication 11-5581, 2011
18. North American Association of Central Cancer Registries: North American Association of Central Cancer Registries (NAACCR) Guideline for Enhancing Hispanic/Latino Identification. Revised NAACCR Hispanic/Latino Identification Algorithm [NHIA v2.2.1]. Springfield, IL, North American Association of Central Cancer Registries, 2011
19. Au WY, Ma SY, Chim CS, et al: Clin-icopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: A single center experience of 10 years. Ann Oncol 16: 206-214, 2005
20. Quintanilla-Martinez L, Franklin JL, Guerrero I, et al: Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: High prevalence of p53 overexpression. Hum Pathol 30: 849-855, 1999
21. Montealegre JR, Zhou R, Amirian ES, et al: Uncovering nativity disparities in cancer patterns: Multiple imputation strategy to handle missing nativity data in the Surveillance, Epidemiology, and End Results data file. Cancer 120: 1203-1211, 2014
22. Pinheiro PS, Bungum TJ, Jin H: Limitations in the imputation strategy to handle missing nativity data in the Surveillance, Epidemiology, and End Results program. Cancer 120: 3261-3262, 2014
23. Rüdiger T, Weisenburger DD, Anderson JR, et al: Non-Hodgkin's Lymphoma Classification Project: Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): Results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 13: 140-149, 2002
24. Chan JK, Sin VC, Wong KF, et al: Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89: 4501-4513, 1997
25. Kanavaros P, Lescs MC, Brière J, et al: Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 81: 2688-2695, 1993
26. Ferreri AJ, Govi S, Pileri SA, et al: Anaplastic large cell lymphoma, ALK-negative. Crit Rev Oncol Hematol 85: 206-215, 2013
27. Ferreri AJ, Govi S, Pileri SA, et al: Anaplastic large cell lymphoma, ALK-positive. Crit Rev Oncol Hematol 83: 293-302, 2012
28. Chang YB, Kaidarova Z, Hindes D, et al: Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors-United States, 2000-2009. J Infect Dis 209: 523-531, 2014
29. Crozier JA, Sher T, Yang D, et al: Persistent disparities among patients with T-cell non-Hodgkin lymphomas and B-cell diffuse large cell lymphomas over 40 years: A SEER database review. Clin Lymphoma Myeloma Leuk 15: 578-585, 2015
30. Jim MA, Arias E, Seneca DS, et al: Racial misclassification of American Indians and Alaska Natives by Indian Health Service Contract Health Service Delivery Area. Am J Public Health 104 S295-S302, 2014